E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/16/2007 in the Prospect News PIPE Daily.

New Issue: Pluristem Life Systems concludes $8 million stock sale

By Sheri Kasprzak

New York, Feb. 16 - Pluristem Life Systems, Inc. wrapped an $8 million private placement.

The company sold to new investors 640 million shares at $0.0125 each.

The investors received one warrant per share, exercisable at $0.025 each.

So far, the company has received $1.25 million from the offering and will receive the remainder by March 15.

Based in Haifa, Israel, Pluristem is a biotechnology company focused on stem cell research.

Issuer:Pluristem Life Systems, Inc.
Issue:Stock
Amount:$8 million
Shares:640 million
Price:$0.0125
Warrants:One warrant per share
Warrant strike price:$0.025
Settlement date:Feb. 14
Stock symbol:OTCBB: PLRS
Stock price:$0.04 at close Feb. 14

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.